MR progress on excessive iron deposition in chronic nervous diseases

Chinese Journal of Medical Imaging Technology

Volumn 25, Issue 11, 2009, Pages 2129-2131

  Miao, Yan Wei ^a   Wu, Jian Lin ^a  

^a DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

Brain iron; Magnetic resonance imaging; Nervous system

Indexed keywords

FREE RADICAL; IRON;

ALZHEIMER DISEASE; IRON STORAGE; LIPID PEROXIDATION; MULTIPLE SCLEROSIS; NEURODEGENERATION WITH BRAIN IRON ACCUMULATION; NUCLEAR MAGNETIC RESONANCE; PARKINSON DISEASE; REVIEW; SUSCEPTIBILITY WEIGHTED IMAGING;

EID: 77956839134     PISSN: 10033289     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (33)

1. Moos T, Nielsen TR, Skjørrmge T, et al. Iron trafficking inside the brain. J Neurochem, 2007, 103(5): 1730-1740.
2. Miao YW, Liu T, Wu JL, et al. Susceptibility weighted imaging evaluation of brain iron metabolism of gray nucleus in healthy people. Chin J Med Imaging Technol, 2009, 25(3): 377-379.
3. Stankiewicz J, Panter SS, Neema M, et al. Iron in chronic brain disorders: imaging and neurotherapeutic implications. Neurotherapeutics, 2007, 4(3): 371-386. (Pubitemid 46962416)
4. Schenck JF. Magnetic resonance imaging of brain iron. J Neurol Sci, 2003, 27(1): 99-102. (Pubitemid 36287110)
5. Graham JM, Paley MN, Grunewald RA, et al. Brain iron deposition in Parkinson's disease imaged using the PRIME magnetic resonance sequence. Brain, 2000, 123(pt12): 2423-2431.
6. Song R, Song HK. Echo-spacing optimization for the simultaneous measurement of reversible (R2′) and irreversible (R2) transverse relaxation rates. J Magn Reson Imaging, 2007, 25(1): 63-68.
7. Jensen JH, Chandra R, Ramani A, et al. Magnetic field correlation imaging. Magn Reson Med, 2006, 55(6): 1350-1361. (Pubitemid 43856773)
8. Wang Y, Yu Y, Li D, et al. Artery and vein separation using susceptibility-dependent phase in contrast-enhanced MRA. J Magn Reson Imaging, 2000, 12(5): 661-670.
9. Haacke EM, Xu Y, Cheng YC, et al. Susceptibility weighted imaging (SWI). Mag Reson Med, 2004, 52(3): 612-618.
10. Haacke EM, Cheng YC, House MJ, et al. Imaging iron stores in the brain using magnetic resonance imaging. J Magn Reson Imaging, 2005, 23(1): 1-25. (Pubitemid 40269946)
11. Haacke BM, Ayaz M, Khan A. Establishing a baseline phase behavior in magnetic resonance imaging to determine normal vs. abnormal iron content in the brain. J Magn Reson Imaging, 2007, 26(2): 256-264. (Pubitemid 47257722)
12. Bartzokis G, Tishler TA. MRI evaluation of basal ganglia ferritin iron and neurotoxicity in Alzheimer's and Huntington's disease. Cell Mol Biol, 2000, 46(4): 821-833.
13. Bakshi R, Benedict RH, Bermel RA, et al. T2 hypointensity in the deep gray matter of patients with multiple sclerosis: a quantitative magnetic resonance imaging study. Arch Neurol, 2002, 59 (1): 62-68. (Pubitemid 34052557)
14. Inglese M, Ge Y, Jensen J, et al. Iron accumulation m the deep gray matter of patients with MS measured by magnetic field correlation. Neurology, 2005, 64(Suppl 1): A236.
15. House MJ, St Pierre TG, Kowdley KV, et al. Correlation of proton transverse relaxation rates (R2) with iron concentrations in postmortem brain tissue from Alzheimer's disease patients. Magn Reson Med, 2007, 57(1): 172-180.
16. Atasoy HT, Nuyan O, Tunc T, et al. T2-weighted MRI in Parkinson's disease; substantia nigra pars compacta hypointensity correlates with the clinical scores. Neurol India, 2004, 52(3): 332-337. (Pubitemid 39430186)
17. Mondino F, Filippi P, Magliola U, et al. Magnetic resonance relaxometry in Parkinson's disease. Neurol Sci, 2002, 23(Suppl 2): S87-S88. (Pubitemid 35355790)
18. Walter U, Wittstock M, Benecke R, et al. Substantia nigra echogenicity is normal in non-extrapyramidal disorders but increased in Parkinson's disease. J Neural Transm, 2002, 109(2): 191-196.
19. Berg D, Hochstrasser H. Iron metabolism in Parkinsonian syndromes. Mov Disord, 2006, 21(9): 1299-1310.
20. Bartzokis G, Cummings JL, Markham CH, et al. MRI evaluation of brain iron in earlier and later-onset Parkinson's disease and normal subjects. J Magn Reson Imaging, 1999, 17(2): 213-222.
21. Kosta P, Argyropoulou MI, Markoula S, et al. MRI evaluation of the basal ganglia size and iron content in patients with Parkinson's disease. J Neurol, 2006, 253(1): 26-32.
22. Honda K, Casadesus G, Petersen RB, et al. Oxidative stress and redoxactive iron in Alzheimer's disease. Ann NY Acad Sci, 2004, 1012: 179-182. (Pubitemid 38453525)
23. House MJ, St Pierre TG, Kowdley KV, et al. Correlation of proton transverse relaxation rates (R2) with iron concentrations in post mortem brain tissue from Alzheimer's disease patients. Magn Reson Med, 2007, 57(2): 172-180.
24. House MJ, St Pierre TG, Foster JK, et al. Quantitative MR imaging R2 relaxometry in elderly participants reporting memory loss. AJNR Am J Neuroradiol, 2006, 27(2): 430-439.
25. Tan IL, van Schijndel RA, Pouwels PJ, et al. MR venography of multiple sclerosis. AJNR Am J Neuroradiol, 2000, 21(6): 1039-1042.
26. Hammond KE, Lupo JM, Xu D, et al. Development of a robust method for generating 7.0 T multichannel phase images of the brain with application to normal volunteers and patients with neurological diseases. Neuroimage, 2008, 39(4): 1682-1692.
27. Ge YL, Zohrabian VM, Grossman RI. Seven-Tesla magnetic resonance imaging: new vision of microvascular abnormalities in multiple sclerosis. Arch Neurol, 2008, 65(6): 812-816.
28. Haacke EM, Makki M, Ge Y, et al. Characterizing iron deposition in multiple sclerosis lesions using susceptibility weighted imaging. J Magn Reson Imaging, 2009, 29(3): 537-544.
29. Mittal S, Wu Z, Neelavalli J, et al. Susceptibility-weighted imaging: technical aspects and clinical applications, part 2. AJNR Am J Neuroradiol, 2009, 30(2): 232-252.
30. Bakshi R, Shaikh ZA, Janardhan V. MRI T2 shortening ("black T2") in multiple sclerosis: frequency, location, and clinical correlation. Neuroreport, 2000, 11(1): 15-21.
31. Tjoa CW, Benedict RH, Weinstock-Guttman B, et al. MRI T2 hypointensity of the dentate nucleus is related to ambulatory impairment in multiple sclerosis. J Neurol Sci, 2005, 234(1-2): 17-24.
32. Neema M, Stankiewicz J, Arora A, et al. T1- and T2-ased MRI measures of diffuse gray matter and white matter damage in patients with multiple sclerosis. J Neuroimaging, 2007, 17(Suppl 1): 16-21.
33. Brass SD, Benedict RH, Weinstock-Guttman B, et al. Cognitive impairment is associated with subcortical magnetic resonance imaging grey matter T2 hypointensity in multiple sclerosis. Mult Scler, 2006, 12(4): 437-444.